Pbx1 suppresses the hematopoietic stem cell growth-enhancing effect of Hoxb4.

被引:0
|
作者
Krosl, J
Beslu, N
Mayotte, N
Humphries, KR
Sauvageau, G
机构
[1] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
[2] Hop Maison Neuve Rosemont, Div Hematol, Montreal, PQ H1T 2M4, Canada
[3] Terry Fox Lab, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1128
引用
收藏
页码:294A / 294A
页数:1
相关论文
共 50 条
  • [1] Pbx1 is negative regulator of Hoxb4-induced stem cell proliferation.
    Beslu, N
    Krosl, J
    Humphries, KR
    Sauvageau, G
    BLOOD, 2001, 98 (11) : 451A - 452A
  • [2] Human PBX1 interacting protein (HPIP) promotes primitive hematopoietic cell growth
    Kaur, Pawandeep
    Arseni, Natalia
    Stadler, Christiane
    Ahmed, Farid
    Cusan, Monica
    Abramovich, Carolina
    Hiddemann, Wolfgang R.
    Humpheries, Keith
    Buske, Christian
    Buske, Michaela Feuring
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (07) : S73 - S74
  • [3] Human PBX1 interacting protein (HPIP) promotes primitive hematopoietic cell growth.
    Kaur, P.
    Arseni, N.
    Ahmed, F.
    Cusan, M.
    Abramovich, C.
    Hiddemann, W.
    Humphries, R. K.
    Buske, C.
    Feuring-Buske, M.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 59 - 59
  • [4] Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1
    Krosl, J
    Baban, S
    Krosl, G
    Rozenfeld, S
    Largman, C
    Sauvageau, G
    ONCOGENE, 1998, 16 (26) : 3403 - 3412
  • [5] Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1
    Jana Krosl
    Soheyl Baban
    Gorazd Krosl
    Sophia Rozenfeld
    Corey Largman
    Guy Sauvageau
    Oncogene, 1998, 16 : 3403 - 3412
  • [6] Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells
    M Shimabe
    S Goyama
    N Watanabe-Okochi
    A Yoshimi
    M Ichikawa
    Y Imai
    M Kurokawa
    Oncogene, 2009, 28 : 4364 - 4374
  • [7] Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells
    Shimabe, M.
    Goyama, S.
    Watanabe-Okochi, N.
    Yoshimi, A.
    Ichikawa, M.
    Imai, Y.
    Kurokawa, M.
    ONCOGENE, 2009, 28 (49) : 4364 - 4374
  • [8] Investigating the biological and molecular mechanisms underpinning the engraftment/selection advantage conferred to hematopoietic stem cells by HOXB4.
    Milsom, MD
    Hollins, L
    Gagen, D
    Woolford, LB
    Fairbaim, LJ
    BLOOD, 2004, 104 (11) : 578A - 578A
  • [9] Roles for c-myc in self-renewal of hematopoietic stem cells as an downstream effector of Notch and HOXB4.
    Satoh, Y
    Matsumura, I
    Ishiko, E
    Ishiko, J
    Tanaka, H
    Sugahara, H
    Kanakura, Y
    BLOOD, 2003, 102 (11) : 141B - 142B
  • [10] Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
    Jung, Jin-Gyoung
    Shih, Ie-Ming
    Park, Joon Tae
    Gerry, Emily
    Kim, Tae Hoen
    Ayhan, Ayse
    Handschuh, Karen
    Davidson, Ben
    Fader, Amanda N.
    Selleri, Licia
    Wang, Tian-Li
    CANCER RESEARCH, 2016, 76 (21) : 6351 - 6361